Lake Street raised the firm’s price target on Koru Medical (KRMD) to $5 from $4 and keeps a Buy rating on the shares after the company announced preliminary Q4 revenue that beat the firm’s and Street’s estimates. While the preliminary release provided limited detail into what drove the beat, the firm suspects broad-based business strength given the size of the beat, the analyst tells investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.